Platelet serotonin level predicts survival in amyotrophic lateral sclerosis.
<h4>Background</h4>Amyotrophic lateral sclerosis (ALS) is a life-threatening neurodegenerative disease involving upper and lower motor neurons loss. Clinical features are highly variable among patients and there are currently few known disease-modifying factors underlying this heterogene...
Guardado en:
Autores principales: | Luc Dupuis, Odile Spreux-Varoquaux, Gilbert Bensimon, Philippe Jullien, Lucette Lacomblez, François Salachas, Gaëlle Bruneteau, Pierre-François Pradat, Jean-Philippe Loeffler, Vincent Meininger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d79b37c074f418c8d2e8f6600ba01a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profiling.
por: Laurence Conraux, et al.
Publicado: (2013) -
Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Alexandre Henriques, et al.
Publicado: (2017) -
Impulsivity, gender, and the platelet serotonin transporter in healthy subjects
por: Donatella Marazziti, et al.
Publicado: (2009) -
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
por: Gabriele Nagel, et al.
Publicado: (2017) -
Amyotrophic lateral sclerosis and frontotemporal degeneration
Publicado: (2000)